SynXT Therapeutics
PrivateLast Round
Grant
Mar 1, 2026
Total Funding Raised
$30,000
Company Overview
SynXT Therapeutics, Inc. is a biotechnology company developing a first-in-class therapy that selectively targets triple negative breast cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SynXT Therapeutics Comps
Public and private peers based on sector, stage, and business model.
SynXT Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 1, 2026 | ||||
| Grant | Aug 1, 2025 | ||||
| Grant | Apr 1, 2025 | ||||
| Grant | Mar 1, 2025 | ||||
| Grant | Dec 1, 2024 |
SynXT Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UWM Research Foundation | Grant |
| The Lynde and Harry Bradley Foundation | Grant |
| Center for Technology Commercialization | Grant |
| Invenergy | Grant |
| NSF I-Corps Program | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
$25K grant from UWM Research Foundation.
- Aug 1, 2025
Received grant funding from UWM Research Foundation, Invenergy, and The Lynde and Harry Bradley Foundation.
SynXT Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SynXT Therapeutics's valuation, stock price, and market status.
